4//SEC Filing
ARCHER TIMOTHY 4
Accession 0000707549-25-000016
CIK 0000707549other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:06 PM ET
Size
20.6 KB
Accession
0000707549-25-000016
Insider Transaction Report
Form 4
ARCHER TIMOTHY
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-05+86,548→ 932,940 total - Exercise/Conversion
Market-based Performance Restricted Stock Unit
2025-02-05−152,000→ 0 totalExercise: $0.00→ Common Stock (152,000 underlying)
Holdings
- 147,260
Market-based Performance Restricted Stock Unit
Exercise: $0.00→ Common Stock (147,260 underlying) - 121,400
Employee Stock Option (Right to Buy)
Exercise: $30.03Exp: 2027-03-02→ Common Stock (121,400 underlying) - 59,970
Employee Stock Option (Right to Buy)
Exercise: $59.88Exp: 2028-03-01→ Common Stock (59,970 underlying) - 147,240
Employee Stock Option (Right to Buy)
Exercise: $98.15Exp: 2031-03-01→ Common Stock (147,240 underlying) - 181,020
Market-based Performance Restricted Stock Unit
Exercise: $0.00→ Common Stock (181,020 underlying) - 181,020
Employee Stock Option (Right to Buy)
Exercise: $49.09Exp: 2030-03-01→ Common Stock (181,020 underlying) - 113,300
Employee Stock Option (Right to Buy)
Exercise: $17.68Exp: 2026-03-01→ Common Stock (113,300 underlying) - 5,670.281(indirect: By Spouse)
Common Stock
- 48,026.049(indirect: By 401(k))
Common Stock
- 151,980
Employee Stock Option (Right to Buy)
Exercise: $54.06Exp: 2029-03-01→ Common Stock (151,980 underlying)
Footnotes (11)
- [F1]On 03/01/2022, the Reporting Person received a target grant of 152,000 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 03/01/2025. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from 02/01/2022 through 01/31/2025.
- [F10]The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022.
- [F11]The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.
- [F2]The amount reported includes shares subject to unvested restricted stock units.
- [F3]The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2025. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2022 through 01/31/2025.
- [F4]The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026.
- [F5]The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2027. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2024 through 01/31/2027
- [F6]The stock options will become exercisable in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025.
- [F7]The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024.
- [F8]The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026.
- [F9]The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.
Documents
Issuer
LAM RESEARCH CORP
CIK 0000707549
Entity typeother
Related Parties
1- filerCIK 0001343600
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 4:06 PM ET
- Size
- 20.6 KB